Tutorial
Robinhood Chain
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Alerts on Telegram
Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Lipocine Inc. (LPCN) · INSIDER
Data sources
SEC Form 4
5h ago
House PTR
5h ago
SEC 13F
5h ago
Robinhood Chain
5h ago
Public company
Lipocine Inc.
LPCN
CIK 0001535955
EDGAR filings
Open in network
○
Watch LPCN
Price
$1.57
1 year
-38.7%
Disclosed transactions
1
Buys / sells
1 / 0
Max Insider Score
33
Connections with evidence
2
Customize layout
LPCN · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
33
HW
Higuchi John W.
Director
LPCN
Lipocine Inc.
Open-market purchase
BUY
$27K
12.6K sh
Sep 28, 2026
Sep 30, 2026
Verified connections
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Insider of
evidence
Higuchi John W.
Director · Sep 30, 2026
traded Sep 28, 2026
+2d
SEC Form 4
Evidence
Evidence
Close
Disclosed trades
TradingView